Jay Zhang is the Co-Founder and President of TriArm Therapeutics, a clinical-stage cell therapy company. A Venture Partner at Panacea Venture, he holds a Ph. D. from the University of Utah and completed postdoctoral training at Stanford University. His mission is to make advanced CAR-T therapies more accessible and affordable globally.
Jay views life science and business through an artistic lens, believing them to be among the most beautiful forms of art. He is passionate about turning the business of life sciences into a masterpiece, moving beyond the simple mechanics of cells and DNA to a more profound appreciation of the field.
He believes that life is the most beautiful art in the universe.